Skip to search formSkip to main contentSkip to account menu

Inhalant Powder

Known as: Powdered Dose Inhaler, Inhalant Powder Dose Form, Inhalant Powder Dosage Form 
Powdered medication inhaled as a measured dose.
National Institutes of Health

Related topics

Related topics

10 relations
Epinephrine 0.22 MG Inhalant PowderGlycopyrrolate 0.0156 MG / indacaterol 0.0275 MG Inhalant Powder [Utibron]Glycopyrrolate 0.0156 MG Inhalant Powder [Seebri]Tobramycin 28 MG Inhalant Powder [Tobi]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
AFREZZA® (insulin human) Inhalation Powder: A Review in Diabetes Mellitus
Afrezza® (insulin human) inhalation powder is a rapid-acting Technosphere® insulin (TI) administered via a breath-powered oral… 
Review
2013
Review
2013
Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials
Introduction: Inhaled antibiotics are probably the safest and most effective therapy for Pseudomonas aeruginosa chronic lung… 
Highly Cited
2011
Highly Cited
2011
Insulin Lung Deposition and Clearance Following Technosphere® Insulin Inhalation Powder Administration
ABSTRACTPurposeTo determine distribution and deposition of Technosphere® Insulin (TI) inhalation powder and the rate of clearance… 
Highly Cited
2010
Highly Cited
2010
Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol
Abstract Objective: To report performance characteristics and robustness of the Breezhaler device, a new capsule based dry powder… 
2009
2009
Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial.
OBJECTIVE This study assessed pulmonary safety following discontinuation and readministration of inhaled human insulin {Exubera… 
Highly Cited
2007
Highly Cited
2007
Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety
Aerosolized antibiotics are associated with a high treatment burden that can result in non‐adherence to chronic therapy. We… 
Highly Cited
2005
Highly Cited
2005
Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.
Highly Cited
2004
Highly Cited
2004
Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers.
A multicenter, randomized, open-label, crossover study with two 4-week evaluation periods compared patient preference and ease of… 
Highly Cited
2002
Highly Cited
2002
Lactose modifications enhance its drug performance in the novel multiple dose Taifun DPI.
Highly Cited
2000
Highly Cited
2000
Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease.
Tiotropium (Spiriva; Ba679BR) is a new-generation, long-acting anticholinergic bronchodilator that has muscarinic M(1) and M(3… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)